Aflibercept Injection as Prophylaxis Against Conversion to Exudative AMD in High-risk Eyes

This randomized clinical trial evaluates the use of intravitreal aflibercept as prophylaxis against conversion to exudative age-related macular degeneration (AMD) in patients with dry AMD and high risk for conversion.
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research